CompoAtlas

Super Diet Protocole détox bio (Phase 1)

Food supplement declared in France, declaration No 2016-10-754

Super Diet Protocole détox bio (Phase 1) (Super Diet) is a food supplement declared in France. Status: retiré du marché le 2 January 2021. None of the rules we check flags an issue with its declared composition.

Brand
Super Diet
Food business operator placing the product on the market
LABORATOIRES SUPER DIET
Status
Retiré du marché le 2 January 2021
Form
Ampoule
Daily dose
1 ampoule
Directions for use
Les 10 premiers jours , prendre 1 ampoule par jour dans un demi-verre d’eau
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Allergie aux dérivés salicylés, Enfants (moins de 12 ans), Femmes enceintes, Problèmes de foie, Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Détoxifiant / Draineur

Declaration 276762, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Desmodium adscendens (Sw.) DC.FeuilleExtrait fluide aqueux300 mg
Cynara cardunculus subsp. flavescens WiklundFeuilleExtrait sec aqueux255 mg
Rosmarinus officinalis L.FeuilleExtrait fluide aqueux50 mg
Cynara cardunculus subsp. flavescens WiklundFeuilleExtrait fluide aqueux45 mg
Raphanus sativus L.RacineAutre extrait fluide7.5 ml

Barcode for this product: 3428881238102 (composition read from Open Food Facts on 20 March 2026, identical to the declaration for active ingredients; doses are not compared).

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Les précautions d'emploi reprises sont valables sur le produit dans sa totalité, ainsi pour les 3 phases. Dans autres dans consommation déconseillée (non visible) : Déconseillé aux personnes souffrant d’allergie aux dérivés salicylés, à l’artichaut et aux plantes de la famille des Astéracées. Déconseillé en cas d’obstruction intestinale, de calculs biliaires et maladie hépatique ou biliaire. Si vous suivez un traitement, demandez l’avis de votre médecin. En cas de traitement pour la thyroïde et d’hypothyroïdie, demandez l’avis de votre médecin. Toute démarche de drainage est déconseillée en cas d’oedèmes liés à une insuffisance cardiaque ou rénale et doit se faire dans le cadre d’une alimentation équilibrée et associée à la consommation d’environ 1,5 litre d’eau par jour.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Cynara cardunculus subsp. flavescens Wiklund
    Read the warning, when it applies and the studies cited

    Globe Artichoke - Cynara Cardunculus

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Barnes et al. 2007; Mills and Bone 2005; ESCOP 2003).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones (Brinker 2010; Mills and Bone 2005; ESCOP 2003; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Digestive disturbance/dyspepsia/Help increase bile flow.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you have a bile duct obstruction (EMA 2018; Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (EMA 2018; Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 2000).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • Rosmarinus officinalis L.
    Read the warning, when it applies and the studies cited

    ROSEMARY – ROSMARINUS OFFICINALIS Oral

    Route of administration: Oral (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

    ROSEMARY - ROSMARINUS OFFICINALIS Topical

    Route of administration: Topical (ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have large open wounds, skin lesions, feverish conditions, acute inflammation, severe circulatory disorders or hypertension (ESCOP 2003).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Barnes et al. 2007; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Super Diet

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line